BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24555608)

  • 1. Rate of malignancy in MRI-detected probably benign (BI-RADS 3) lesions.
    Spick C; Szolar DH; Baltzer PA; Tillich M; Reittner P; Preidler KW; Pinker-Domenig K; Helbich TH
    AJR Am J Roentgenol; 2014 Mar; 202(3):684-9. PubMed ID: 24555608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probably benign breast MRI lesions: frequency, lesion type, and rate of malignancy.
    Lourenco AP; Chung MT; Mainiero MB
    J Magn Reson Imaging; 2014 Apr; 39(4):789-94. PubMed ID: 24108546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
    Gutierrez RL; DeMartini WB; Eby PR; Kurland BF; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic work-up of non-palpable breast lesions classified as probably benign at initial mammography and/or ultrasound (BI-RADS category 3).
    Gruber R; Jaromi S; Rudas M; Pfarl G; Riedl CC; Flöry D; Graf O; Sickles EA; Helbich TH
    Eur J Radiol; 2013 Mar; 82(3):398-403. PubMed ID: 22429299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign (BI-RADS 2) lesions in breast MRI.
    Spick C; Szolar DH; Tillich M; Reittner P; Preidler KW; Baltzer PA
    Clin Radiol; 2015 Apr; 70(4):395-9. PubMed ID: 25649442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of a breast MRI score for the prediction of malignancy of breast lesions detected solely with MRI].
    Siegmann KC; Moron HU; Baur A; Hahn M; Vogel U; Claussen CD; Bitzer M
    Rofo; 2009 Jun; 181(6):556-63. PubMed ID: 19452398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.
    Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
    AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of probably benign breast MRI lesions.
    Eby PR; DeMartini WB; Gutierrez RL; Saini MH; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Sep; 193(3):861-7. PubMed ID: 19696303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of malignancy in lesions classified as probably benign after dynamic contrast-enhanced breast MRI examination.
    Sadowski EA; Kelcz F
    J Magn Reson Imaging; 2005 May; 21(5):556-64. PubMed ID: 15834907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
    Linda A; Zuiani C; Furlan A; Lorenzon M; Londero V; Girometti R; Bazzocchi M
    AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.
    Hambly NM; Liberman L; Dershaw DD; Brennan S; Morris EA
    AJR Am J Roentgenol; 2011 Jan; 196(1):218-24. PubMed ID: 21178070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size.
    Linda A; Zuiani C; Londero V; Bazzocchi M
    Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
    Gökalp G; Topal U
    Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
    Oztekin PS; Kosar PN
    Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical indication and patient age predict likelihood of malignancy in suspicious breast MRI lesions.
    Gutierrez RL; Demartini WB; Eby P; Kurland BF; Peacock S; Lehman CD
    Acad Radiol; 2009 Oct; 16(10):1281-5. PubMed ID: 19733804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BI-RADS® 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?
    Bahrs SD; Baur A; Hattermann V; Hahn M; Vogel U; Claussen CD; Siegmann-Luz KC
    Acta Radiol; 2014 Apr; 55(3):260-5. PubMed ID: 23969262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up frequency and compliance in women with probably benign findings on breast magnetic resonance imaging.
    Marshall AL; Domchek SM; Weinstein SP
    Acad Radiol; 2012 Apr; 19(4):406-11. PubMed ID: 22227041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
    Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
    Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category.
    Seely JM; Nguyen ET; Jaffey J
    Acta Radiol; 2007 Oct; 48(8):838-45. PubMed ID: 17851971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up results of BI-RADS 3 lesions on magnetic resonance imaging: a retrospective study.
    Aslan Ö; Oktay A; Eroğlu F
    Diagn Interv Radiol; 2024 May; 30(3):175-182. PubMed ID: 38293846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.